KAREN KAYE: Open Payments
NPI 1407188709 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,444 in 65 payments from 9 companies in 2025. Trend: 2023 $657 · 2024 $833 · 2025 $5,444
Consulting: $3,000Food & beverage: $1,819Travel & lodging: $625
| Company | Payments | Amount |
|---|---|---|
| Genentech USA, Inc. | 8 | $3,955 |
| EMD Serono, Inc. | 30 | $613 |
| TG Therapeutics, Inc. | 10 | $379 |
| Biogen, Inc. | 8 | $269 |
| Genentech, Inc. | 3 | $84 |
| Amgen Inc. | 2 | $47 |
| ABBVIE INC. | 2 | $44 |
| Celgene Corporation | 1 | $33 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
Products named: Ocrevus, BRIUMVI, TYSABRI, Ocrevus Zunovo, UPLIZNA, QULIPTA, ZEPOSIA, VUMERITY.
Industry payments across GA — which companies pay providers there.
